Organigram Holdings Inc. reported a loss of $2.8 million in its latest quarter as its gross revenue rose 90 per cent compared with a year ago.
The cannabis company says the loss amounted to 0.9 of a cent per share for the quarter ended May 31 compared with a loss of $4 million or 1.4 cents per share a year earlier.
Gross revenue in what was the company’s third quarter totalled $55.2 million, up from $29.1 million in the same quarter last year.
Net revenue was $38.1 million, up from $20.3 million.
Organigram CEO Beena Goldenberg says the company achieved record net revenue and it expects to top it again in its fourth quarter on the strength of new product listings, increased retail sales momentum and international shipments.
The company says its market share in the quarter amounted to 7.8 per cent.
This report by The Canadian Press was first published July 14, 2022.
- Is fatherhood more appealing than motherhood? What new research shows
- Ottawa appeals court ruling that found use of Emergencies Act ‘unreasonable’
- RCMP dealing with ‘cyber event’ targeting networks, launches criminal probe
- For families struggling with infertility, IVF access poses more difficulty: experts